1. Home
  2. SFBC vs SLN Comparison

SFBC vs SLN Comparison

Compare SFBC & SLN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SFBC
  • SLN
  • Stock Information
  • Founded
  • SFBC 1953
  • SLN 1994
  • Country
  • SFBC United States
  • SLN United Kingdom
  • Employees
  • SFBC N/A
  • SLN N/A
  • Industry
  • SFBC Savings Institutions
  • SLN Biotechnology: Pharmaceutical Preparations
  • Sector
  • SFBC Finance
  • SLN Health Care
  • Exchange
  • SFBC Nasdaq
  • SLN Nasdaq
  • Market Cap
  • SFBC 127.6M
  • SLN 123.3M
  • IPO Year
  • SFBC N/A
  • SLN N/A
  • Fundamental
  • Price
  • SFBC $49.94
  • SLN $3.14
  • Analyst Decision
  • SFBC
  • SLN Buy
  • Analyst Count
  • SFBC 0
  • SLN 5
  • Target Price
  • SFBC N/A
  • SLN $40.80
  • AVG Volume (30 Days)
  • SFBC 2.8K
  • SLN 292.1K
  • Earning Date
  • SFBC 05-02-2025
  • SLN 05-15-2025
  • Dividend Yield
  • SFBC 1.53%
  • SLN N/A
  • EPS Growth
  • SFBC N/A
  • SLN N/A
  • EPS
  • SFBC 1.80
  • SLN N/A
  • Revenue
  • SFBC $35,777,000.00
  • SLN $43,258,000.00
  • Revenue This Year
  • SFBC N/A
  • SLN N/A
  • Revenue Next Year
  • SFBC N/A
  • SLN N/A
  • P/E Ratio
  • SFBC $27.74
  • SLN N/A
  • Revenue Growth
  • SFBC N/A
  • SLN 36.71
  • 52 Week Low
  • SFBC $39.15
  • SLN $1.97
  • 52 Week High
  • SFBC $55.99
  • SLN $24.38
  • Technical
  • Relative Strength Index (RSI)
  • SFBC 46.97
  • SLN 49.25
  • Support Level
  • SFBC $49.48
  • SLN $2.63
  • Resistance Level
  • SFBC $50.26
  • SLN $2.95
  • Average True Range (ATR)
  • SFBC 0.87
  • SLN 0.43
  • MACD
  • SFBC -0.07
  • SLN 0.11
  • Stochastic Oscillator
  • SFBC 58.47
  • SLN 72.67

About SFBC Sound Financial Bancorp Inc.

Sound Financial Bancorp Inc operates as the holding company for Sound Community Bank that provides traditional banking and other financial services for individuals and businesses. It attracts retail and commercial deposits from the public and invests those funds, along with borrowed funds, in loans secured by first and second mortgages on one-to-four-family residences including home equity loans and lines of credit, commercial and multifamily real estate, construction and land, consumer and commercial business loans. The bank also offers secured and unsecured consumer loan products, including manufactured home loans, floating home loans, automobile loans, boat loans, and recreational vehicle loans.

About SLN Silence Therapeutics Plc American Depository Share

Silence Therapeutics PLC is a biotechnology company focused on discovering and developing novel molecules incorporating short-interfering ribonucleic acid or siRNA. Using its mRNAi GOLD platform, the company has generated siRNA product candidates both for internal development pipeline as well as for out-licensed programs with third-party collaborators. Its wholly owned pipeline is focused on three therapeutic areas: cardiovascular disease, hematology, and rare diseases. The different product candidates in its pipeline are Divesiran (SLN124), a siRNA product candidate that has the potential to treat several hematological disorders; Zerlasiran (SLN360), being developed as a potential treatment to reduce cardiovascular issues; SLN-312; SLN-548; and multiple other programs.

Share on Social Networks: